BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data at HFSA Annual Meeting
03.10.2022 - Clinical Leadership and Management Call Scheduled for Wednesday, October 5, 2022, at 8:55am Eastern TimeSUNNYVALE, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) - BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for ... Seite 1